Evidence map›Paper›PMID 40558083›Full record

ArticleBiopolymers2025

Elucidating Mechanisms of Gelation, Fiber Assembly, and Stability of Injectable Decellularized Extracellular Matrix Biomaterials.

Alexander Chen, Michael B Nguyen, Julian Cheng, Benjamin D Bridgelal, Kate E Reimold, Joshua Tesoro, Estefania Encisco-Pelayo, Karen L Christman

Abstract read
In one paragraph

Article in Biopolymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander ChenProgram in Materials Science and Engineering, University of California San Diego, California, USA.ORCID https://orcid.org/0000-0002-8396-8759
Michael B NguyenSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0000-0003-1847-4557
Julian ChengSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0009-0003-7637-9096
Benjamin D BridgelalSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0009-0007-8986-5201
Kate E ReimoldSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0009-0006-5353-4614
Joshua TesoroSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0009-0008-6429-3304
Estefania Encisco-PelayoSanford Consortium for Regenerative Medicine, University of California San Diego, California, USA.ORCID https://orcid.org/0009-0000-3619-8651
Karen L ChristmanProgram in Materials Science and Engineering, University of California San Diego, California, USA.ORCID https://orcid.org/0000-0002-6179-898X

Funding

Training in Multi-Scale Analysis of Biological Structure and FunctionT32EB009380 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrew D. McCulloch, Padmini Rangamani · 2009 to 2026
$4.8M
Infusible Extracellular Matrix for Treating Myocardial InfarctionR01HL165232 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTMAN, KAREN L · 2022 to 2025
$2.9M
Injectable Biomaterial for Treating Hypoplastic Left Heart SyndromeR01HL146147 · NHLBI · EMORY UNIVERSITY · PI CHRISTMAN, KAREN L, DAVIS, MICHAEL E · 2019 to 2022
$2.8M
American Heart Association 24PRE1180449NHLBI NIH HHS R01 HL146147NHLBI NIH HHS R01HL146147NHLBI NIH HHS R01 HL165232NHLBI NIH HHS R01HL165232NHLBI NIH HHS T32EB009380NHLBI NIH HHS T32HL0074444NIBIB NIH HHS T32 EB009380
6 · The paper itself

Abstract

Decellularized extracellular matrix (dECM)-based biomaterials have been widely used for their applications in tissue engineering. In particular, pepsin digestion of dECM can be used to generate injectable forms, including ECM hydrogels as well as an intravascularly infusible ECM (iECM). However, fundamental materials characterization of these materials has been limited, and thus little is known about what exactly drives gelation of ECM hydrogels or the conditions for fibril assembly and growth. With this study, we sought to answer a fundamental question on how these materials assemble or gel, as well as a translational question on what storage conditions are suitable for these materials. Here, we used second-harmonic generation and transmission electron microscopy to investigate the mechanism of gelation for ECM hydrogels and the nanofibril assembly of the iECM. Overall, these microscopies revealed the origin and morphology of self-assembly and that type I collagen lateral and longitudinal growth drives ECM hydrogel formation. On the contrary, the iECM preserved the same mechanism for nanofiber assembly without gelation. In terms of translation, ensuring the stability after rehydration is critical for therapeutic injection timing since changes in the material could impact both safety and efficacy. Via microscopy in conjunction with bulk material characterization, we found that dECM formulations are best kept at 4°C for a maximum of 24 h after rehydration in order to maintain their original properties. Overall, this work provides evidence for the type I collagen directed self-assembly within heterogeneous, injectable, decellularized ECM biomaterials and also determines clinically relevant material storage conditions.

Indexed as

Biocompatible MaterialsDecellularized Extracellular MatrixExtracellular MatrixHydrogelsNanofibersAnimalsCollagen Type ITissue EngineeringBiocompatible MaterialsCollagen Type IDecellularized Extracellular MatrixHydrogelsdecellularized extracellular matrixhydrogelintravascularself‐assembly

Identifiers

PMID40558083
PMCPMC12188951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.